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AbsTrACT
International research collaborations improve individual, 
institutional and governmental capacities to respond 
to health crises and inequalities but may be greatly 
affected by political environments. Iran ranks highly 
in tertiary education, productivity growth, knowledge 
impact and successful patent applications. In many 
countries, economic hardship has correlated with 
increased international research collaborations. Some 
have hypothesised that financial constraint drives scholars 
to seek outside collaborations for cost and risk sharing, 
and to access funding, materials and patient populations 
otherwise unavailable. This paper explores the history 
and importance of US political sanctions on the health 
of Iran’s academic sector. Although Iran’s international 
research collaborations increased during periods of 
increased sanctions, the Pearson correlation coefficient 
between gross domestic product and international 
research collaborations was not significant (r=0.183, 
p=0.417). This indicates that other factors are at least in 
part responsible. Additionally, we found Iran’s quantitative 
(eg, publication number) and qualitative (eg, visibility 
indices) publishing metrics to be discordant (two-tailed 
Mann–Kendall trend; p<0.0002 for both). Reasons for this 
are multifactorial, including increased indexing of Iranian 
journals, willingness of lower visibility journals to handle 
manuscripts with Iranian authors, widespread linkage 
of career advancement to science visibility indices, and 
others. During periods of increased sanctions, Iranian 
scholars were increasingly denied opportunities to publish 
scientific findings, attend scientific meetings, access to 
essential medical and laboratory supplies and information 
resources. We conclude that academic boycotts violate 
researchers’ freedom and curtail progress. Free exchange 
of ideas irrespective of creed is needed to optimize global 
scientific progress.
InTroduCTIon
Globalisation is enhanced by international 
scientific and research collaboration.1 2 Rates 
of international research collaboration have 
increased sharply in recent decades, with 
internationally co-authored papers rising 
from 13.2% (2000) to 19.2% (2013).3 4 
International research collaborations benefit 
society, enrich scientific lives and facilitate 
networking.5 Moreover, manuscripts, journal 
strength and citation numbers increase.6 
Reasons for the rapid expansion of inter-
national research collaborations include: 
(1) improved research capacity (individual 
and institutional); (2) resource sharing1; 
(3) access to specialists (or patient popula-
tion) not proximately available; (4) helping 
the scientific community stay up-to-date on 
cutting-edge advancements7; and (5) miti-
gating health inequities.8 9 As such, inter-
national research collaborations are less a 
research quality indicator than a means to 
reach it.9
Information technology and communica-
tion systems improvements (particularly the 
internet) have facilitated rapid and exten-
sive exchange of information, expertise and 
ideas across political, linguistic and cultural 
summary box
 ► Global rates of international research collaboration 
have increased sharply in recent decades
 ► Iran’s international research collaboration rate rose 
over recent periods of increased sanctions; however, 
evidence suggests that factors other than economic 
restrictions may be influencing this.
 ► Iran’s publication rates have risen during recent pe-
riods of increased sanctions; however, its quantita-
tive and qualitative metrics are discordant.
 ► Reasons for Iran’s publication discordance may 
include increased indexing of Iranian journals in 
scholarly databases, willingness of lower visibility 
journals to handle manuscripts with Iranian authors, 
widespread linkage of career advancement to sci-
ence visibility indices, and others.
 ► The World Medical Association rejects academic 
sanctions or boycotts and calls on all national med-
ical associations to resist the imposition of such re-
strictions by every means at their disposal.
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barriers.3 8 In particular, inexpensive and readily available 
modalities such as ResearchGate (ResearchGate Gmbh, 
Berlin, Germany), Mendeley (Mendeley Ltd, London, 
UK), LinkedIn (Microsoft Corp, Sunnyvale, California, 
USA), Facebook (Facebook Inc, Menlo Park, California, 
USA) and Twitter (Twitter Inc, San Francisco, California, 
USA) have facilitated an explosion in international 
research collaborations and data sharing.3 Moreover, 
video call and teleconference technologies defray travel 
and meeting costs. Academics, practitioners and policy-
makers alike have access to networks to coordinate and 
facilitate projects and foster dialogue, engagement and 
collective action.2 10 11
Despite its merits, international research collabora-
tion can be greatly affected by political environments 
including political sanctions and academic boycotts. This 
is currently the case in Iran. We endeavoured to examine 
the impact of US-imposed political and economic sanc-
tions on international research collaborations among 
Iranian entities.
sAnCTIons And IrAn
History
At the international level, sanctions are state-supported 
measures aimed to coerce another to conform to an 
international agreement or conduct norms, typically 
by restrictions in trade or official sporting participa-
tion. Over recent decades they have increasingly been 
used as an alternative to armed conflict. In 2010, Iran 
faced sanctions from the United Nations (UN) Security 
Council (Resolution No 1929) over issues regarding its 
nuclear programme.12 In 2015, Iran and a group of world 
powers including the USA, UK, France, Russia, Germany 
and China (so called P5 +1) agreed on a nuclear deal 
framework in the Joint Comprehensive Plan of Action.13 
According to this agreement, Iran was required to 
reduce its nuclear activities and facilities significantly for 
economic sanctions to be lifted. Despite early success, the 
US government later announced (May 2018) its intent 
to withdraw from this agreement and reinstate sanctions 
aimed to undermine Iran’s nuclear and military indus-
tries.12 14
General economic impact
Iran is the third most populous Eastern Mediterranean 
country.15 The economic sanctions limiting foreign trade 
cooperation with Iran (and entities doing business with 
Iran) have extended far beyond the initial intended 
purpose.16 The ban on aircraft parts endangered lives.17 
The fuel trade ban resulted in forced substitution of 
imported fuel with poorly refined domestic fuel, causing 
adverse health effects from increased air and environ-
mental pollution.18 19 As crude oil exports and associ-
ated revenues decreased, the foreign holdings of finan-
cial institutions were frozen, banks were isolated from 
the global financial system and imports were restricted. 
Access to the dollar and euro (needed to import a range 
of goods) decreased, and as the currency was devalued, 
inflation, unemployment and poverty rose. Moreover, as 
Iran’s economic health declined, inflation has fluctuated 
widely, household incomes have fallen and the health and 
welfare of its people (and neighbours) has been jeopard-
ised in ways previously demonstrated in Burundi, Cuba, 
Haiti, Iraq, Nicaragua and the former Yugoslavia.17 20 21
scientific and health impact
The economic sanctions imposed on Iran undermined 
the transfer of scientific knowledge, technology, medi-
cation and impeded research collaboration. Iranian 
healthcare needs are mainly provided by the govern-
ment. As a significant portion of governmental income 
is derived from oil exports, economic sanctions targeting 
oil exports directly impaired health services. The health 
services decline has limited critical medication access.22 23 
Hinderances of quality control technologies and pharma-
ceutical production have disrupted medication produc-
tion and distribution.24 25
The health effects of sanctions may be due in part to 
deterioration of social determinants of health including: 
income, social status, employment, social environments 
and personal coping skills.26 Moreover, the most vulner-
able are the most affected.27 28 According to the WHO, 
death rates due to self-harm rose from 5.9 to 6.1 per 
100 000 persons during the 2011–2014 period, returning 
to 5.9 1 year after the sanctions were lifted. Moreover, 
deaths due to interpersonal violence rose from an average 
of 2.0 to 2.7 per 100 000 persons during the period of the 
sanctions.29 These trends, along with a corresponding 
increase in substance abuse,30 31 likely reflect a deteriora-
tion in healthcare during the period of intense economic 
sanctions.26
Unfortunately, the reach of the effects has extended 
beyond Iran to the greater Middle East region. Iran ranks 
third globally for hosted refugees, and incurs great cost 
to provide them with medical care.32 Additionally, Iran 
treats >300 000 medical tourists (2013) annually from 
neighbouring countries including Afghanistan, Azer-
baijan, Bahrain, Iraq, Kuwait, Lebanon, Pakistan, Saudi 
Arabia, Syria, Turkey and Turkmenistan.33 Furthermore, 
Iran supports medical care, health research and medical 
education growth in Afghanistan, Iraq and other neigh-
bouring countries. In Afghanistan, Iran provides free 
polio vaccines, has worked to improve the quality of 
blood transfusion methods and product, and even estab-
lished the first organ transplantation centre.
ImpACT of sAnCTIons on IrAn’s reseArCH And 
publIsHInG
Iran has a young population, with 40% of the population 
aged ≤25 years (figure 1).34 35 In recent years, enrollment 
in tertiary educational institutions has risen from 154 000 
(1975) to 4 083 000 (2017),36 with education expendi-
tures exceeding the global average.37 Iran ranks high 
globally in science and engineering graduates (3rd), 
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Figure 1 Iranian urban and non-urban population.
Figure 2 Rates of international research collaboration: (A) Comparison of Iran with the five Middle East countries that 
collaborate the most with them. (B) Comparison of Iran with the five countries (any region) that collaborate the most with them. 
(C) Comparison of Iran with the five countries that engage in the most international collaboration.
tertiary education (3rd), knowledge impact (12th) and 
science and technical publications (32nd).38 39 As recently 
as 1996, Iran ranked first globally for manuscripts with 
international collaboration (figure 2C).40
International research collaboration
Despite economic restrictions, Iran’s international 
research collaboration rate rose from 2010 to 2015; 
however, numbers lagged behind those of many western 
(Canada, Germany, USA, UK), Middle Eastern (KSA, 
Iraq, Qatar, Egypt) and Asian countries (China, Japan, 
Malaysia) (figure 2).40 The reason for this rise is multifac-
torial. First, Iranian entities may have needed to engage 
in external collaboration to continue academic pursuits 
given a scarcity of resources, funding and applied external 
blockades. The drop in Iran’s international research 
collaborations when sanctions were lessened from 1996 
to 2004 lends credence to this hypothesis. Similar rises 
in international research collaborations were observed 
during periods of sanctions and financial constraint in Iraq 
following the second Iraq war (figure 2A).40 Additionally, 
similar trends were observed in many western countries 
(Australia, Canada, UK, USA) following the financial crisis 
of 2007–2008 (figure 2B).40 To assess this we calculated the 
Pearson correlation coefficient between gross domestic 
product (GDP) and international research collabora-
tions (see online Supplemental appendix 1 for methods). 
Although suggestive, the relationship between Iran’s GDP 
and international research collaborations was not signifi-
cant (r=0.183, p=0.417), suggesting other non-economic 
factors are also influencing this observation.41
A second factor contributing to the increase in Iran’s 
international research collaborations is communica-
tion technologies. Data sharing and social networking 
websites have enabled researchers to collaborate in ways 
not previously possible. Data are currently lacking to 
further assess this relationship.
Lastly, the greater meaning implied by an increase in 
international research collaborations is not clear. A high 
level of international research collaboration could indi-
cate either dependence or expertise. It is unclear which 
(if either) applies to Iran.
publishing
Publication metrics may be viewed quantitatively (eg, 
publication number) or qualitatively (eg, visibility 
indices). Qualitative metrics are important as article 
numbers only describe the basis of visibility, not the 
perception.
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As recently as 1996, Iran led other leading coun-
tries (China, Germany, Japan, UK, USA) in terms of 
manuscripts with international research collaborations 
(figure 2).40 However, as of 2017 they ranked last among 
the same cohort. Even so, Iran’s publication totals have 
followed global trends by rising steadily since 2011 
(table 1). Despite trailing western nations, Iran and 
Turkey account for nearly half of all Organisation of 
Islamic Cooperation (OIC) member country scientific 
manuscripts.42 To investigate whether the rise in Iran’s 
publications during recent periods of increased US 
sanctions is linked to Iran’s economic stress, a two-tailed 
Mann–Kendall trend was performed for both quantita-
tive and qualitative metrics (see online Supplemental 
appendix for methods). Discordance was observed 
between Iran’s quantitative and qualitative global and 
Middle East rankings (figure 3; p<0.0002 for both).43 44
The reasons for these findings are multifactorial, 
including increased indexing of Iranian journals, willing-
ness of lower visibility journals to handle manuscripts with 
Iranian authors, widespread linkage of career advance-
ment to science visibility indices, and others. In the two 
decades following Iran’s revolution, almost no articles 
published in Iranian journals were cited or indexed in 
databases such as PubMed.45 In the past 15 years, however, 
the number of Iranian journals (and requisite citations) 
cited in PubMed has rapidly increased,45 resulting in 
improved article identification.
Additionally, widespread linkage of career advance-
ment to science visibility indices may be contributing 
as well. Iranian policy makers adopted an approach 
whereby scientists were assessed based on science visi-
bility indexes, including the number of publications in 
indexed journals.45 In the past two decades Iran began to 
support the development of internationally recognised 
journals and has used publications as a main indicator 
of performance.45 This has contributed to the increased 
publication numbers in indexed journals by Iranian 
entities.
As pertains to the discordance between Iran’s quantita-
tive and qualitative metrics, publishing embargoes likely 
play a role. Owing to fear of unwittingly violating the terms 
of the sanctions, many journal and publishers displayed 
an unwillingness to handle manuscripts with Iranian 
authors (or entities). As such, many Iranian authors were 
forced to publish findings in fledgling (newly indexed) 
journals, thereby decreasing their overall visibility.
scientific innovation
Lastly, despite sanctions, Iran has demonstrated steady 
growth in scientific innovation. Iran rose 10 positions 
to 65th globally (16th of 34 middle-income countries) 
in the 2018 Global Innovation Index, a measure based 
on 80 innovation performance indicators.39 Their major 
strength is the Innovation Efficiency Ratio (ranked 11th 
globally), a measure of how much innovation output a 
given country is getting for its inputs.39 Iran ranks high 
globally in productivity growth (1st),42 knowledge impact 
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Figure 3 (A) Number of available papers of the top five countries in the world along with Iran. (B) Number of available papers 
of the top five countries in the Middle East.
(12th) and patents by origin (14th; 1st among OIC 
members).38 39 However, it performs weakly in the areas 
of investment and knowledge absorption.19
sAnCTIon effICACy And ACAdemIA’s response
Modern science is vulnerable to political sanctions. The 
World Medical Association (WMA) describes academic 
sanctions or boycotts as 'discriminatory restrictions on 
academic, professional and scientific freedoms that 
deny or exclude physicians and others from educational, 
cultural and scientific meetings and other opportunities 
for the exchange of information and knowledge, the 
purpose of such restrictions being to protest the social 
and political policies of governments'.18 By discrimi-
nating against physicians and patients on grounds of 
political persuasion (or decisions of their governments), 
academic boycotts particularly affect the healthcare of 
the vulnerable and disadvantaged; often sparing the very 
populations that prompted the sanctions.24 The WMA 
rejects such restrictions and calls on all national medical 
associations 'to resist the imposition of such restrictions 
by every means at their disposal'.4
Available evidence suggests that academic boycotts 
are not successful tools to achieve political ends. For 
example, South Africa experienced an academic boycott 
over apartheid policies. One study found that 57.3% of 
South African academics reported directly experiencing 
the effects of boycott tactics including manuscript rejec-
tion, denied opportunities to participate in scientific 
meetings, denied international research collaboration 
opportunities or impaired information resource access.46 
Similarly, Iraq sanctions resulted in impaired access to 
medical literature, inability to publish in western journals, 
denied opportunities to participate in scientific meet-
ings, scarce medical supplies and an overall deterioration 
of the health system.47 A similar fate has now befallen 
Iranian scientists. The blockade of currency exchange 
prevents paying fees (publication, registration, member-
ship),25 impeding international research collaborations44 
and causing many journals (and publishing companies) 
to refuse to handle papers submitted by Iranian enti-
ties.48 49 Furthermore, IP address blocking can further 
limit access to software and online resources. The impact 
of this cannot be overstated. Beyond impeding produc-
tivity and progress, sanctions directly impede the promo-
tion and tenure process of Iran’s academics, thereby 
limiting income and their ability to care for their families. 
Metrics such as the Impact Factor have become an inte-
gral part of the promotion and tenure process in Iranian 
universities. Being blocked from publishing, forced to 
publish in lower impact journals and obstructed from 
presenting at international meetings prevents or delays 
academics from reaching institutional benchmarks for 
career advancement.
Publishing embargoes were criticised by the Committee 
on Publication Ethics (COPE), which indicated that 'edito-
rial decisions should not be affected by the origins of the 
manuscript, including the nationality, ethnicity, political 
beliefs, race, or religion of the authors.50 Furthermore, 
decisions to edit and publish should not be determined 
by the policies of governments or other agencies outside 
of the journal itself'.51 Subsequently, Elsevier changed 
its policy stating that manuscripts submitted by authors 
from sanctioned countries may be handled if they have 
one of the following criteria: (1) the author is not acting 
as an official representative of a sanctioned government; 
(2) (s)he acts on behalf of his government’s education or 
research institution; or (3) he/she is publishing on behalf 
of his government institution which is not primarily an 
educational or research institution and the journal does 
not suggest substantive editing.50 52 Despite this, many 
editors remain conservative due to the fear of penalty or 
liability since instructions for manuscript handling and 
the definition of government employee remain unclear.53
Some publishers have sought to level the playing field 
by lowering barriers and defending the journal’s right to 
publish for merit rather than political will.54 55 The BMJ 
Publishing Group has waived publication fees for open 
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access publications heralding from Iran to bypass bank 
transaction barriers. The Lancet declared that it welcomes 
research from scholars of all countries, including Iran.48 
They added that:
‘We are disappointed that some publishers have created 
the impression that work from Iran should be discriminat-
ed against. This attitude is contrary to the spirit and values 
of global science. We are currently working to deepen our 
relationship with Iranian medical and public health scien-
tists, and we look forward to publishing the results of that 
collaboration, which, we hope, will include Iran's Ministry 
of Health’.56
Beyond publishing woes, foreign-sponsored clinical 
trials in Iran have been terminated or suspended. For 
example, a Wellcome Trust initiative to reduce urban 
health inequalities in six pilot cities (including Tehran) 
was prevented by obstructing research funds transfer 
from the UK to Iran.57 Similarly, researchers at the Tehran 
University of Medical Sciences who teamed up with inves-
tigators at the Icahn School of Medicine at Mount Sinai 
in New York City for a US National Institutes of Health-
funded study on cardiovascular disease patterns in Iran’s 
Golestan province received similar bad news when Mount 
Sinai was unable to transfer the Iranian share of the grant 
to Tehran.58
After the P5 +1 agreement on lifting sanctions according 
to the Joint Comprehensive Plan of Action, advance-
ments in Iranian higher education, research and relief 
of publishing restrictions were expected.42 However, the 
US withdrawal from the agreement, and subsequent new 
sanctions, has again derailed scientific progress. What is 
different this time is that the US government has threat-
ened criminal prosecution of US citizens, residents and 
scientists who collaborate with Iranian entities.59
ConClusIon
Globalisation is enhanced by international research 
collaborations. Information sharing and international 
collaboration is key to mastering the challenges the 
modern world faces. Although we found an increase in 
Iran’s international research collaborations and publi-
cations during periods of increased sanctions, data 
suggest that other non-economic factors are at least in 
part responsible. During periods of increased sanctions, 
Iranian scholars were increasingly denied opportuni-
ties to publish scientific findings, attend scientific meet-
ings, access to essential medical and laboratory supplies, 
and information resources. We conclude that academic 
boycotts violate researchers’ freedom and curtail 
progress. Free exchange of ideas irrespective of creed is 
needed to optimise global scientific progress.
Author affiliations
1Healthcare and Law Department, School of Health Policy and Management, 
Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands
2Department of Emergency Medicine, East Carolina University Brody School of 
Medicine, Greenville, North Carolina, USA
3Department of Anesthesiology and Critical Care, School of Medicine, Hamadan 
University of Medical Sciences, Hamadan, Iran
4Chemical Injuries Research Center, Systems Biology and Poisonings Institute, 
Baqiyatallah University of Medical Sciences, Tehran, Iran
5Department of Epidemiology and Biostatistics, Baqiyatallah University of Medical 
Sciences, Tehran, Iran
6Scientific Information Database, Tehran, Iran
7Gastroenterology and Liver Diseases Research Center, Shaheed Beheshti 
University of Medical Sciences, Tehran, Iran
8Department of Epidemiology, Iran University of Medical Sciences, Tehran, Iran
9Trauma Research Center, Nursing Faculty, Baqiyatallah University of Medical 
Sciences, Tehran, Iran
Contributors All authors have contributed to each stage of manuscript design and 
preparation.
funding The authors have not declared a specific grant for this research from any 
funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
patient consent for publication Not required.
provenance and peer review Not commissioned; externally peer reviewed.
data availability statement All discussed data is publically available. No 
additional data is available.
open access This is an open access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which 
permits others to distribute, remix, adapt, build upon this work non-commercially, 
and license their derivative works on different terms, provided the original work is 
properly cited, appropriate credit is given, any changes made indicated, and the 
use is non-commercial. See: http:// creativecommons. org/ licenses/ by- nc/ 4. 0/.
REFEREnCES
 1. Varnai P, Rentel M, Dave A, et al. The impact of collaboration: the 
value of UK medical research to EU science and health. Technopolis 
Group 2017:1–82.
 2. Freshwater D, Sherwood G, Drury V. International research 
collaboration. Int J Nurs Res 2006;11:295–303.
 3. Luukkonen T, Tijssen RJW, Persson O, et al. The measurement of 
international scientific collaboration. Scientometrics 1993;28:15–36.
 4. Witze A. Research gets increasingly international. Nature 
2016;785:6–8.
 5. Grathwol RP. The world through a different window: an international 
perspective on research. Physiologist 2005;48:169–71.
 6. Dale R, Robertson S. Globalisation and Europeanisation in 
education. Oxford: Symposium Books Ltd, 2009.
 7. Hayati Z, Didegah F. International scientific collaboration 
among Iranian researchers during 1998‐2007. Library Hi Tech 
2010;28:433–46.
 8. Bettcher D, Lee K. Globalisation and public health. J Epidemiol 
Community Health 2002;56:8–17.
 9. Kim K-W. Measuring international research collaboration of 
peripheral countries: taking the context into consideration. 
Scientometrics 2006;66:231–40.
 10. McKee M, Gilmore AB, Schwalbe N. International cooperation and 
health. Part I: Issues and concepts. J Epidemiol Community Health 
2005;59:628–31.
 11. McKee M, Gilmore AB, Schwalbe N. International cooperation and 
health. Part 2: Making a difference. J Epidemiol Community Health 
2005;59:737–9.
 12. United Nations Security Council. UN Security Council resolution 
1929, 2010. Available: https:// undocs. org/ S/ RES/ 1929( 2010) 
[Accessed 27 Dec 2018].
 13. US Department of State. Joint Plan of Action (JPOA) archive 
and Joint Comprehensive Plan of Action (JCPOA) archive, 2018. 
Available: https://www. treasury. gov/ resource- center/ sanctions/ 
Programs/ Pages/ jpoa_ archive. aspx [Accessed 27 Dec 2018].
 14. Mulligan SP. Withdrawal from international agreements: legal 
framework, the Paris agreement, and the Iran nuclear agreement. 
Congressional Research Service 2018:1–28.
 15. World Health Organization. Country cooperation strategy for WHO 
and the Islamic Republic of Iran 2010-2014. WHO regional office 
for the Eastern Mediterranean, 2010. Cairo. Available: http:// apps. 
who. int/ iris/ bitstream/ 10665/ 113238/ 1/ CCS_ Islamic_ Republic_ Iran_ 
2010_ EN_ 14482. pdf [Accessed 31 May 2019].
4300.7802.430. Protected by copyright.
 o
n
 Septem
ber 18, 2019 at Erasm
us M
edical / X51
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2019-001692 on 3 September 2019. Downloaded from 
Kokabisaghi F, et al. BMJ Global Health 2019;4:e001692. doi:10.1136/bmjgh-2019-001692 7
BMJ Global Health
 16. US Department of the Treasury. Sanctions programs and country 
information, 2018. Available: https://www. treasury. gov/ resource- 
center/ sanctions/ Programs/ Pages/ Programs. aspx [Accessed 15 Sep 
2018].
 17. Kokabisaghi F. Economic sanctions as social determinants of health. 
Shiraz E-Med J 2017;18(Suppl):e58662.
 18. Mousavi S, Jokar F, Mohammadi A. US unilateral sanctions against 
Iran; contradiction in slogan and conduct, extreme politicization of 
human rights. Pub Law Res 2015;16:149–73.
 19. Mousavi SFJ, Mohammadi O, Roshan NAM, et al. The impacts of 
economic sanctions on sustainable development: focusing on labor. 
Cumhuriyet Sci J 2015;36:3458–76.
 20. Kokabisaghi F. Assessment of the effects of economic sanctions on 
Iranians' right to health by using human rights impact assessment 
tool: a systematic review. Int J Health Policy Manag 2018;7:374–93.
 21. Six charts that show how hard US sanctions have hit Iran, 2019. 
BBC News. Available: https://www. bbc. com/ news/ world- middle- 
east- 48119109 [Accessed 31 May 2019].
 22. Kheirandish M, Varahrami V, Kebriaeezade A, et al. Impact of 
economic sanctions on access to noncommunicable diseases 
medicines in the Islamic Republic of Iran. East Mediterr Health J 
2018;24:42–51.
 23. Namazi S. Sanctions and medical supply shortages in Iran. 
Viewpoints 2013;20:1–9.
 24. Moret ES. Humanitarian impacts of economic sanctions on Iran and 
Syria. Eur Sec 2015;24:120–40.
 25. Massoumi RL, Koduri S. Adverse effects of political sanctions on the 
health care system in Iran. J Glob Health 2015;5:020302.
 26. Aloosh M, Salavati A, Aloosh A. Economic sanctions threaten 
population health: the case of Iran. Public Health 2019;169:10–13.
 27. Asadi-Pooya AA, Azizimalamiri R, Badv RS, et al. Impacts of the 
International economic sanctions on Iranian patients with epilepsy. 
Epilepsy Behav 2019;95:166–8.
 28. Ghiasi G, Rashidian A, Kebriaeezadeh A, et al. The impact of the 
sanctions made against Iran on availability to asthma medicines in 
Tehran. Iran J Pharm Res 2016;15:567–71.
 29. Institute for Health Metrics and Evaluation. Global health data 
exchange. Seattle: University of Washington, 2019.
 30. Deilamizade A, Esmizade S. Economic sanctions against Iran, and 
drug use in Tehran, Iran: a 2013 pilot study. Subst Use Misuse 
2015;50:859–68.
 31. Shariatirad S, Maarefvand M. Sanctions against Iran and the 
impact on drug use and addiction treatment. Int J Drug Policy 
2013;24:636–7.
 32. Hosseini Divkolaye NS, Burkle FM, Frederick M. The enduring health 
challenges of Afghan immigrants and refugees in Iran: a systematic 
review. PLoS Curr 2017;9. doi:10.1371/ currents. dis. 449b 4c54 9951 
e359 363a 90a7 f4cf8fc4. [Epub ahead of print: 21 Jul 2017].
 33. International Healthcare Association. Health tourism in Iran and the 
Middle East, 2018. Available: http:// internationalhta. com/ [Accessed 
27 Dec 2018].
 34. Mundi I. Iran demographics profile 2018, 2018. Available: https://
www. indexmundi. com/ iran/ demographics_ profile. html [Accessed 27 
Dec 2018].
 35. Statistical Center of Iran. Iranian urban and non-urban population 
trends, 2018. Available: https://www. amar. org. ir/ english [Accessed 5 
Jan 2019].
 36. Growth by 2500% of students and universities after the revolution, 
2018. Tasnim news. Available: https://www. tasnimnews. com/ fa/ 
news/ 1396/ 11/ 18/ 1649269 [Accessed 27 Dec 2018].
 37. United Nations. United Nations common country assessment for the 
Islamic Republic of Iran, 2003. United nations. Available: http://www. 
tr. undp. org/ content/ dam/ rbap/ docs/ programme- documents/ cca/ IR- 
CCA- 2003. pdf [Accessed 27 Dec 2018].
 38. Alpay S, Maxton J. The atlas of Islamic world science and 
innovation. Organization of Islamic Cooperation 2015:1–49.
 39. Cornell University, INSEAD, World Intellectual Property 
Organization. Global innovation INDEX 2018: Energizing the world 
with innovation. 11th ed. Ithica, Fontainebleau, and Geneva, 2018. 
Available: https://www. glob alin nova tion index. org/ Home [Accessed 
5 Jan 2019].
 40. SCIMAGOJR. Scimago Journal and country RANK. Available: 
https://www. scimagojr. com/ [Accessed 1 Nov 2018].
 41. World Bank Open Data. GDP (current US$): World Bank national 
accounts data, and OECD national accounts data files, 2018. 
Available: https:// data. worldbank. org/ indicator/ NY. GDP. MKTP. CD 
[Accessed 5 Jan 2019].
 42. Mozafari M. Iran and science publishing in the post-sanctions era. 
The Lancet 2016;387:1721–2.
 43. Abramson JH. PEPI-for-Windows: computer programs for 
epidemiologists. Epidemiol Perspect Innov 2004;1.
 44. Scopus. Publishing trends, 2018. Available: https://www. Scopus. 
com [Accessed Nov 2018].
 45. Rezaee-Zavareh MS, Karimi-Sari H, Alavian SM. Iran, sanctions, and 
research collaborations. The Lancet 2016;387:28–9.
 46. Haricombe LJ. Combining qualitative and quantitative 
methodologies to study the effects of an academic boycott on 
academics in South Africa. Libr Q 1993;63:508–27.
 47. Sansom C. The ghost of Saddam and UN sanctions. Lancet Oncol 
2004;5:143–5.
 48. Arie S. Unintended consequences of sanctions against Iran. BMJ 
2013;347:f4650.
 49. Marshall E. Scientific journals adapt to new U.S. trade sanctions on 
Iran, 2013. Science. Available: http://www. sciencemag. org/ news/ 
2013/ 05/ scientific- journals- adapt- new- us- trade- sanctions- iran 
[Accessed 27 Dec 2018].
 50. Seeley M. How sanctions laws affect publishing: OFAC provides 
new guidance: Elsevier has encouraged “freedom of expression” for 
scientific authors in sanctioned countries such as Iran, Cuba, Sudan, 
Burma and Syria. Elsevier, 2015. Available: https://www. elsevier. 
com/ connect/ how- sanctions- laws- affect- publishing- ofac- provides- 
new- guidance [Accessed 17 Aug 2018].
 51. Lankarani KB, Mahmoodi M, Gholami S, et al. Reducing social 
disparity in liver transplantation utilization through governmental 
financial support. Hepat Mon 2012;12:e6463.
 52. Seeley M. Trade sanctions against Iran affect publishers: Elsevier 
explains legal issues to its editors and works with publishers and 
research community to pursue ‘balance in the law’. Elsevier, 2013. 
Available: https://www. elsevier. com/ connect/ trade- sanctions- 
against- iran- affect- publishers [Accessed 17 Aug 2018].
 53. Zarghami M. Illogical and unethical scientific sanctions against 
Iranian authors. Iran J Psych Behav Sci 2013;7:1–4.
 54. Afshari R, Bhopal RS, Iran BRS. Iran, sanctions, and collaborations. 
The Lancet 2016;387:1055–6.
 55. Rose H, Rose S, Israel RS. Israel, Europe and the academic boycott. 
Race Cl 2008;50:1–20.
 56. The Editors of The Lancet. Iran and science publishing: an open 
letter – editors' reply. Lancet 2013;382:596.
 57. Stone R. Science in Iran languishes after Trump reimposes 
sanctions, 2018. Science. Available: http://www. sciencemag. org/ 
news/ 2018/ 08/ science- iran- languishes- after- trump- re- imposes- 
sanctions [Accessed 27 Dec 2018].
 58. Stone R. Renewed sanctions strangle science in Iran. Science 
2018;361:961.
 59. Miller A, Ziad-Miller A. United States federal government regulation 
of international research collaborations: what every physician-
scientist should know. Int J Crit Illn Inj Sci 2019;9:5.
4300.7802.430. Protected by copyright.
 o
n
 Septem
ber 18, 2019 at Erasm
us M
edical / X51
http://gh.bmj.com/
BM
J G
lob Health: first published as 10.1136/bmjgh-2019-001692 on 3 September 2019. Downloaded from 
